一种新的无功能CYP2D6等位基因的克隆与测序：外显子3中T1795的缺失产生了一个提前终止密码子。 - Suppr

Suppr

超能文献

Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon.

作者信息

Evert B, Griese E U, Eichelbaum M

机构信息

Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie, Stuttgart, Germany.

出版信息

Pharmacogenetics. 1994 Oct;4(5):271-4. doi: 10.1097/00008571-199410000-00005.

DOI:10.1097/00008571-199410000-00005

PMID:7894499

Abstract

摘要

相似文献

Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon.一种新的无功能CYP2D6等位基因的克隆与测序：外显子3中T1795的缺失产生了一个提前终止密码子。

Pharmacogenetics. 1994 Oct;4(5):271-4. doi: 10.1097/00008571-199410000-00005.

Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.

Hum Mol Genet. 1994 Jun;3(6):923-6. doi: 10.1093/hmg/3.6.923.

An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution.

Hum Genet. 1995 Mar;95(3):337-41. doi: 10.1007/BF00225204.

A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype.一种具有废除剪接识别位点的新型CYP2D6等位基因，与代谢不良者表型相关。

Pharmacogenetics. 1995 Oct;5(5):305-11. doi: 10.1097/00008571-199510000-00006.

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype.鉴定出一种新的CYP2D6变异等位基因，其缺乏编码赖氨酸-281的密码子：可能与代谢不良者表型相关。

Pharmacogenetics. 1991 Oct;1(1):26-32. doi: 10.1097/00008571-199110000-00005.

Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism.对与异喹胍/司巴丁遗传多态性相关的CYP2D6(A)和CYP2D6(B)无效等位基因的简单聚合酶链反应分析解读

Pharmacogenetics. 1994 Jun;4(3):154-8. doi: 10.1097/00008571-199406000-00006.

An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis.一种使用单链构象多态性分析检测CYP2D6基因已知和新突变的有效策略。

Pharmacogenetics. 1995 Dec;5(6):373-84. doi: 10.1097/00008571-199512000-00006.

Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.异喹胍氧化的基因多态性：CYP2D6突变等位基因的限制性片段分析和等位基因特异性扩增

Methods Enzymol. 1991;206:173-83. doi: 10.1016/0076-6879(91)06088-k.

Identification of a new non-functional CYP2C18 allele in Japanese: substitution of T204 to A in exon2 generates a premature stop codon.在日本人中鉴定出一种新的无功能CYP2C18等位基因：外显子2中T204被A取代产生了一个提前终止密码子。

Pharmacogenetics. 1996 Feb;6(1):117-9. doi: 10.1097/00008571-199602000-00011.

DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.

Hum Genet. 1994 Oct;94(4):401-6. doi: 10.1007/BF00201601.

引用本文的文献

genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort.基因型有助于预测慢性下腰痛阿片类药物治疗期间的有效性和安全性：一项意大利队列回顾性研究的结果

Pharmgenomics Pers Med. 2018 Oct 24;11:179-191. doi: 10.2147/PGPM.S181334. eCollection 2018.

The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol.强效选择性β3肾上腺素能受体激动剂米拉贝隆对细胞色素P450 2D6底物地昔帕明和美托洛尔药代动力学的影响。

Eur J Drug Metab Pharmacokinet. 2014 Mar;39(1):43-52. doi: 10.1007/s13318-013-0133-1. Epub 2013 Jun 1.

Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist.细胞色素 P450 同工酶 3A 和 2D6 在 β3-肾上腺素能受体激动剂米拉贝隆体内代谢中的作用。

Clin Drug Investig. 2013 Jun;33(6):429-40. doi: 10.1007/s40261-013-0084-y.

Cytochrome P450 2D6.细胞色素P450 2D6

Pharmacogenet Genomics. 2009 Jul;19(7):559-62. doi: 10.1097/FPC.0b013e32832e0e97.

Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors.EGAPP工作小组的建议：对使用选择性5-羟色胺再摄取抑制剂治疗的非精神病性抑郁症成年患者进行细胞色素P450基因多态性检测。

Genet Med. 2007 Dec;9(12):819-25. doi: 10.1097/gim.0b013e31815bf9a3.

Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.曲马多在CYP2D6快代谢型和慢代谢型患者中的对映体选择性药代动力学

Eur J Clin Pharmacol. 2006 Jul;62(7):513-21. doi: 10.1007/s00228-006-0135-x. Epub 2006 Jun 9.

Identification of CYP2D6 impaired functional alleles in Mexican Americans.墨西哥裔美国人中CYP2D6功能受损等位基因的鉴定。

Eur J Clin Pharmacol. 2005 Dec;61(11):797-802. doi: 10.1007/s00228-005-0044-4. Epub 2005 Nov 8.

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.高加索人群中的细胞色素P450 2D6变体：等位基因频率及表型后果

Am J Hum Genet. 1997 Feb;60(2):284-95.

Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.去甲替林及其10-羟基代谢物的稳态血浆水平：与CYP2D6基因分型的关系。

Psychopharmacology (Berl). 1996 Feb;123(4):315-9. doi: 10.1007/BF02246640.

Molecular basis of polymorphic drug metabolism.多态性药物代谢的分子基础。

J Mol Med (Berl). 1995 Nov;73(11):539-53. doi: 10.1007/BF00195139.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验